吡唑并嘧啶作为靶向抗癌支架——综述。

IF 1.9 4区 医学 Q3 CHEMISTRY, MEDICINAL
Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham
{"title":"吡唑并嘧啶作为靶向抗癌支架——综述。","authors":"Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham","doi":"10.2174/0115734064251256231018104623","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.</p><p><strong>Objectives: </strong>The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.</p><p><strong>Methods: </strong>The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.</p><p><strong>Results: </strong>This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.</p><p><strong>Conclusion: </strong>The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.</p>","PeriodicalId":18382,"journal":{"name":"Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.\",\"authors\":\"Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham\",\"doi\":\"10.2174/0115734064251256231018104623\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.</p><p><strong>Objectives: </strong>The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.</p><p><strong>Methods: </strong>The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.</p><p><strong>Results: </strong>This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.</p><p><strong>Conclusion: </strong>The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.</p>\",\"PeriodicalId\":18382,\"journal\":{\"name\":\"Medicinal Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0115734064251256231018104623\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734064251256231018104623","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:在全球范围内,癌症是主要的死亡原因,每年导致1000万人死亡。临床上,有几种药物用于治疗,但由于耐药性和多药耐药性,癌症治疗会失败。目的:综述吡唑和嘧啶杂化物作为潜在抗癌药物的研究进展。方法:综述了该领域60多项研究成果。讨论了已报道的吡唑并嘧啶稠合杂环的效率及其生物学数据以及分子结构方面的影响。结果:本文着重介绍吡唑并嘧啶类药物作为靶向抗癌药物,具有多种靶点作用。结论:该综述将有助于癌症靶向药物研究人员设计吡唑并嘧啶部分的新型支架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.

Background: Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.

Objectives: The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.

Methods: The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.

Results: This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.

Conclusion: The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinal Chemistry
Medicinal Chemistry 医学-医药化学
CiteScore
4.30
自引率
4.30%
发文量
109
审稿时长
12 months
期刊介绍: Aims & Scope Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信